❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
❤️Conditions & CareResearchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
Researchers analyzing data from 2,610 diffuse large B-cell lymphoma patients found that a shorter interval between diagnosis and treatment actually reflects underlying di…
🧠AI AnalysisA large international retrospective study has evaluated the outcomes of bridging therapy in patients with relapsed or refractory large B-cell lymphoma receiving CD19-dire…
Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.